HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kun Tang Selected Research

Solitary Pulmonary Nodule

3/2019The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
1/2018Spectral CT Analysis of Solitary Pulmonary Nodules for Differentiating Malignancy from Benignancy: The Value of Iodine Concentration Spatial Distribution Difference.
1/2018The Value of 18F-FDG PET/CT Mathematical Prediction Model in Diagnosis of Solitary Pulmonary Nodules.
7/2015Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kun Tang Research Topics

Disease

36Neoplasms (Cancer)
07/2022 - 01/2014
16Inflammation (Inflammations)
03/2022 - 01/2014
12Neoplasm Metastasis (Metastasis)
12/2021 - 01/2014
8Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2014
6Kidney Calculi (Kidney Stone)
02/2022 - 10/2017
6Nephrocalcinosis
01/2022 - 12/2019
6Prostatic Neoplasms (Prostate Cancer)
12/2021 - 05/2017
6Renal Cell Carcinoma (Grawitz Tumor)
09/2021 - 12/2014
6Carcinogenesis
01/2021 - 05/2015
5Asthma (Bronchial Asthma)
03/2022 - 09/2020
4Lymphatic Metastasis
12/2021 - 09/2019
4Carcinoma (Carcinomatosis)
01/2020 - 08/2013
4Solitary Pulmonary Nodule
03/2019 - 07/2015
4Atherosclerosis
07/2018 - 01/2017
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022 - 04/2020
3Hydronephrosis
09/2021 - 01/2020
3Adenocarcinoma of Lung
01/2021 - 11/2015
3Lung Neoplasms (Lung Cancer)
12/2020 - 11/2015
3Hypoxia (Hypoxemia)
01/2020 - 01/2015
2COVID-19
06/2022 - 01/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2021
2Pain (Aches)
07/2021 - 04/2015
2Non-alcoholic Fatty Liver Disease
04/2021 - 10/2020
2Atherosclerotic Plaque (Atheroma)
04/2021 - 01/2018
2Pyonephrosis
03/2021 - 01/2020
2Sarcopenia
01/2021 - 11/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 10/2017
2Leukemia
10/2020 - 10/2013
2Acquired Immunodeficiency Syndrome (AIDS)
04/2020 - 06/2015
2Infections
01/2020 - 06/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2017
2Reperfusion Injury
11/2018 - 12/2017
2Hyperlipidemias (Hyperlipidemia)
07/2018 - 01/2017
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2018 - 01/2014
2Inborn Genetic Diseases (Disease, Hereditary)
01/2018 - 01/2012
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 01/2017
2Kidney Neoplasms (Kidney Cancer)
01/2017 - 10/2014
1Glioma (Gliomas)
10/2022
1Ovarian Neoplasms (Ovarian Cancer)
10/2022
1Disease Progression
06/2022
1Rheumatic Diseases (Rheumatism)
06/2022

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2014
12Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2021 - 07/2015
9Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2006
8MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
7CytokinesIBA
03/2022 - 01/2014
7Biological ProductsIBA
12/2021 - 05/2014
6Calcium OxalateIBA
01/2022 - 12/2019
5LipidsIBA
02/2021 - 08/2010
5Long Noncoding RNAIBA
01/2021 - 11/2015
5Pharmaceutical PreparationsIBA
01/2020 - 04/2004
4Therapeutic UsesIBA
07/2022 - 01/2020
4Competitive Endogenous RNAIBA
12/2021 - 12/2014
4C-Reactive ProteinIBA
01/2021 - 01/2014
4glyoxylic acid (glyoxylate)IBA
01/2021 - 01/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 01/2017
3Messenger RNA (mRNA)IBA
07/2018 - 10/2013
3FlavonoidsIBA
05/2018 - 05/2014
3CholesterolIBA
01/2018 - 08/2010
2Interleukin-10 (Interleukin 10)IBA
03/2022 - 10/2020
2Interleukin-4 (Interleukin 4)IBA
03/2022 - 09/2020
2sulforaphaneIBA
01/2022 - 01/2020
2RNA (Ribonucleic Acid)IBA
12/2021 - 01/2021
2Circular RNAIBA
12/2021 - 01/2021
2GlobulinsIBA
09/2021 - 01/2021
2Hemoglobins (Hemoglobin)IBA
09/2021 - 11/2016
2AlbuminsIBA
09/2021 - 01/2021
2Glucose (Dextrose)FDA LinkGeneric
04/2021 - 10/2020
2Oxygen (Dioxygen)IBA
11/2020 - 11/2014
2Free RadicalsIBA
11/2020 - 01/2015
2Indicators and Reagents (Reagents)IBA
10/2020 - 01/2017
2Serum AlbuminIBA
01/2020 - 10/2018
2Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
01/2020 - 01/2020
2LDL Receptors (LDL Receptor)IBA
07/2018 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
07/2018 - 01/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2018 - 02/2015
2Peptides (Polypeptides)IBA
07/2018 - 01/2006
2Apolipoproteins E (ApoE)IBA
05/2018 - 01/2018
2dihydromyricetinIBA
05/2018 - 01/2017
2Analgesics (Analgesic Drugs)IBA
03/2018 - 01/2014
2puerarinIBA
01/2018 - 01/2017
2Androgen Receptors (Androgen Receptor)IBA
01/2018 - 08/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2013
1Small Leucine-Rich ProteoglycansIBA
10/2022
1Metal-Organic FrameworksIBA
07/2022
1COVID-19 VaccinesIBA
06/2022
1VaccinesIBA
06/2022
1Immunoglobulin E (IgE)IBA
03/2022
1prednylidene (Pred)IBA
03/2022

Therapy/Procedure

10Therapeutics
07/2022 - 01/2013
4Percutaneous Nephrolithotomy
02/2022 - 01/2016
4Drug Therapy (Chemotherapy)
12/2021 - 05/2014
3Radiotherapy
12/2021 - 05/2014
3Length of Stay
03/2021 - 01/2014
3Blood Transfusion (Blood Transfusions)
03/2021 - 01/2014
3Prostatectomy (Retropubic Prostatectomy)
11/2020 - 05/2017
3Operative Time
11/2016 - 01/2014
2Immunotherapy
07/2022 - 12/2021
2Lasers (Laser)
11/2021 - 01/2014
2Contraception (Birth Control)
10/2021 - 04/2020